12:00 AM
 | 
Sep 10, 2003
 |  BC Extra  |  Clinical News

Genesis, SR Pharma start Phase II eczema trial

Genesis Research (ASE:GEN) and SR Pharma (LSE:SPA) started a placebo-controlled New Zealand Phase II...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >